Khalil Salame

This study was designed to characterize the vertebral body (VB) shape, focusing on vertebral wedging, along the thoracic and lumbar spine, and to look for shape variations with relation to gender, age, and ethnicity. All thoracic and lumbar (T1-L5) dissected vertebrae of 240 individuals were measured and analyzed by age, gender, and ethnicity. A 3D digitizer was used to measure all VB lengths, heights, and widths, and their ratios were calculated. This study showed that the VB size was independent of age or ethnicity. VB left lateral wedging was found in most vertebrae of most individuals, yet systematically was absent in six vertebrae (T4, T8-T9, T11, L3-L4) with a greater tendency in females than males ( approximately 92% vs. 86%). The VB was anteriorly wedged from T1 through L2 (peak at T7), nonwedged at L3, and posteriorly wedged at L4-L5 (peak at L5). VB width decreased from T1 to T4 and then increased toward L4-L5, so that the spinal configuration in the coronal plane resembled two pyramids of opposite directions, sharing an apex at T4. The inferior VB width was significantly greater than the superior width of both the same vertebra and the adjacent lower vertebra, indicating a trapezoidal shape of the VB and an inverted trapezoidal shape of the intervertebral space. In conclusion, these findings indicate that the human vertebra, in its normal condition, maintains its external dimensions with age, independent of gender or ethnic origin. Clinical and surgical implications of the unique thoracolumbar architecture are discussed.

OBJECT: A retrospective study analyzing medical files of patients who had undergone surgical management for cervical spondylotic myelopathy (CSM) at a single tertiary hospital was performed to determine the time needed by community care physicians to reach a diagnosis of CSM in patients presenting with typical myelopathic signs and symptoms, and to establish the reasons for the delayed diagnosis when present. Previous studies have documented that early diagnosis and surgical treatment of CSM may improve patients' neurological as well as general outcome. However, patients complaining of symptoms compatible with CSM may undergo lengthy medical investigations and treatments by community-based physicians before a correct diagnosis is made. The authors have found no published data on the process and time frame involved in attaining a diagnosis of CSM in the community setting. METHODS: The medical records of 42 patients were retrospectively reviewed for demographic data, symptoms, time to diagnosis, physician specialty, number of visits involved in the diagnostic process, and neurological status prior to surgery. RESULTS: The mean time delay from initiation of symptoms to diagnosis of CSM was 2.2 ± 2.3 years. The majority of symptomatic patients (90.4%) initially presented to a family practitioner (69%) or an orthopedic surgeon (21.4%), with fewer patients (9.6%) referring to other disciplines (for example, the emergency department) for initial care. In contrast, the diagnosis of CSM was most often made by neurosurgeons (38.1%) and neurologists (28.6%), and less frequently by orthopedic surgeons (19%) or family physicians (4.8%). CONCLUSIONS: The diagnosis of CSM in the community is frequently delayed, leading to late referral for surgery. A higher index of suspicion for this debilitating entity is required from family practitioners and community-based orthopedic surgeons to prevent neurological sequelae.

BACKGROUND AND OBJECTIVE: The purpose of the present study was to examine the recovery of the crushed sciatic nerve of rats after low-power laser irradiation applied to the corresponding segments of the spinal cord. STUDY DESIGN/MATERIALS AND METHODS: After a crush injury to the sciatic nerve in rats, low-power laser irradiation was applied transcutaneously to corresponding segments of the spinal cord immediately after closing the wound by using 16 mW, 632 nm He-Ne laser. The laser treatment was repeated 30 minutes daily for 21 consecutive days. RESULTS: The electrophysiologic activity of the injured nerves (compound muscle action potentials--CMAPs) was found to be approximately 90% of the normal precrush value and remained so for up to a long period of time. In the control nonirradiated group, electrophysiologic activity dropped to 20% of the normal precrush value at day 21 and showed the first signs of slow recovery 30 days after surgery. The two groups were found to be significantly different during follow-up period (P < 0.001). CONCLUSION: This study suggests that low-power laser irradiation applied directly to the spinal cord can improve recovery of the corresponding insured peripheral nerve.

BACKGROUND: Intracranial hemorrhage, either spontaneous or traumatic is a well-known and potentially lethal complication of Warfarin treatment. Patients with Warfarin-related intracranial hemorrhage need urgent reversal of anticoagulation that must be especially rapid if surgical intervention is indicated. The traditional treatment with fresh frozen plasma (FFP) and vitamin K often fails to achieve the desired correction of coagulopathy in urgent neurosurgical settings. CASE REPORT: In the present case Recombinant Coagulation Factor VIIa (rFVIIa) was used for preoperative reversal of Warfarin-related coagulopathy. The patient was a fifty two years old man, mechanic valve recipient with Warfarin-induced coagulopathy: International Normalization Ratio (INR) of 6.39, who suffered from acute subdural hematoma and needed urgent neurosurgical intervention. He received a single dose of rFVIIa 120 mg/kg and immediately underwent craniotomy and evacuation of the hematoma. Appropriate hemostasis was achieved during surgery and coagulation test taken two hours after rFVIIa injection revealed INR of 1.25. The INR remained normalized for additional 14 hours. To the best of our knowledge, this is the first report on the use of rFVIIa in the preoperative management of Warfarin-induced intracranial hemorrhage. RESULTS: Recombinant Coagulation Factor VIIa provides rapid correction of coagulation to a level that allows safe neurosurgical intervention without significant delay. This agent is safe and effective; and should be considered for reversal of Warfarin-induced coagulopathy in cases of intracranial hemorrhage, especially when urgent surgical intervention is required.